Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Abbott Laboratories' stock rose 1.77% to $125.46, outperforming competitors during a generally poor trading session. This marks the stock's third consecutive day of gains, closing 11.17% below its 52-week high. In comparison, Johnson & Johnson, Pfizer, and Merck saw smaller gains. Trading volume was 1.6 million below the 50-day average. The data was compiled on December 12, 2025, by MarketWatch.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments